Human NT2 teratocarcinoma cells differentiate into neuron-like NT2-N cells when treated with retinoic acid. GABA evoked concentration-dependent whole-cell currents in NT2-N cells with an EC 50 of 21.8 M and a Hill slope of 1.2. GABA A receptor (GABAR) currents reversed at E ClϪ and did not display voltagedependent rectification. GABAR single channels opened in bursts to a 23 pS main conductance level and a 19 pS subconductance level, with infrequent openings to a 27 pS conductance level. Kinetic properties of the main conductance level were similar to other native and recombinant GABAR channels. Diazepam and zolpidem enhanced GABAR currents with moderate affinity, whereas methyl-6,7-dimethoxy-4-ethyl-␤-carboline-3-carboxylate inhibited GABAR currents. Loreclezole enhanced GABAR currents with high affinity, but furosemide antagonized GABAR currents with low affinity. The neurosteroids alphaxalone and pregnenolone sulfate appropriately modulated GABAR currents. Zinc blocked GABAR currents with low affinity, but lanthanum did not significantly alter NT2-N GABAR currents. Reverse transcription PCR (RT-PCR) performed on RNA from NT2-N cells clearly detected transcripts encoding human ␣2, ␣3, ␣5, ␤3, ␥3, and subtypes. The combined pharmacological and RT-PCR results are most consistent with a single or predominant GABAR isoform composed of an ␣2 and/or ␣3 subtype combined with the ␤3 and ␥3 subtypes. The data do not rule out receptors containing combinations of ␣2 and/or ␣3 subtypes with the ␣5 subtype or receptors with both ␤1 and ␤3 subtypes. The presence or absence or the subunit in functionally expressed receptors could not be determined.
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GABA is the major inhibitory neurotransmitter in the vertebrate brain. Fast IPSPs are mediated by GABA A receptors (GABARs), which contain binding sites for many modulators including benzodiazepines, barbiturates, general anesthetics, penicillin, picrotoxin, bicuculline, and zinc. GABARs consist of five subunits that form a chloride ion channel. Four different subunit families (␣, ␤, ␥, and ␦) have been studied extensively (Macdonald and Olsen, 1994) , and two new subunit families, (Hedblom et al., 1997) and ⑀ (Davies et al., 1997) , have been identified recently. In addition, in mammals, including humans, six ␣ (␣1-␣6), three ␤ (␤1-␤3), and three ␥ (␥1-␥3) subtypes have been described. Pharmacological studies of recombinant receptors have shown that individual subunits and their subtypes confer different sensitivities to GABAR modulators such as benzodiazepines (Pritchett et al., 1989; Wieland et al., 1992) and zinc (Draguhn et al., 1990) . The subunit subtypes are differentially expressed throughout development and in different CNS regions , reducing the total number of possible isoforms that can be formed in different brain regions and in individual cells.
Studies of GABARs in human CNS neurons have been difficult because of heterogeneity of cell types and unknown GABAR subtype expression. For example, in isolated human central neurons, the heterogeneity of cell types has led to a wide range of responses to GABAR modulators, presumably because of differing subunit composition (Gibbs et al., 1996) . It has not been possible to isolate a homogeneous population of postmitotic neurons from human brain and maintain them in culture for detailed pharmacological and biochemical studies. Electrophysiological studies of neuronal GABARs, therefore, have relied on nonhuman neurons in primary cell cultures or acutely isolated neuron preparations. However, the transcriptional, translational, and post-translational processing, assembly, transport, and subcellular localization performed by a heterogeneous population of rodent neurons may not adequately reflect the behavior of human neurons.
The NT2-N human neuronal cell line offers a useful bridge between studies of defined recombinant receptors expressed in non-neuronal cell lines and studies of native nonhuman receptors. Prolonged treatment of the human NT2 teratocarcinoma cell line with retinoic acid causes these pluripotential cells to become terminally differentiated into neurons termed NT2-N cells (Pleasure et al., 1992) . After differentiation, NT2-N cells extend both dendritic and axonal processes and express neuron-specific cell surface, cytoskeletal, and secretory markers and functional neurotransmitter receptors (Pleasure et al., 1992; Younkin et al., 1993; Munir et al., 1995; Beczkowska et al., 1997) . Levels of protein kinases A and C have also been shown to increase in NT2 cells during differentiation (Abraham et al., 1991) , which may be important in regulating the function of these receptors and other cellular processes. In addition, recent reports have shown the existence of synaptic connections between cells in culture (Hartley et al., 1997) . In this study we demonstrated that NT2-N cells expressed functional human GABARs with relatively homogeneous properties, suggesting that NT2-N cells may provide a useful model system for investigation of human GABARs assem-bled and expressed in a homogeneous population of human neurons.
MATERIALS AND METHODS
Cell culture. N T2 cells were grown and maintained in DM EM high glucose (HG) with 10% fetal bovine serum, and penicillin and streptomycin were added as previously described (Andrews, 1984) . C ells were plated at 2 ϫ 10 6 cells/75 cm 2 flask and differentiated by treatment with 1 M retinoic acid (R A) for 4 weeks. After R A treatment, cells were washed with versene and then treated with trypsin to dislodge the cells. C ells were resuspended after being triturated and replated at a 1:10 dilution with DM EM HG and maintained in 5% C O 2 . The following day the media was removed and saved as conditioned media to feed replates II and III. C ells were again treated with trypsin and then spun for 5 min at 1000 rpm. The pellet was resuspended in 1 ml of media containing mitotic inhibitors (in M: 10 5-fluoro-2Јdeoxyuridine plus 10 uridine and 1 cytosine arabinoside) and replated (replate II). The same treatment was performed again after 1 week in culture (replate III) to obtain ϳ100% pure neurons. These cells were replated onto 35 mm Corning (Corning, N Y) dishes for electrophysiological recording. For these experiments we limited selection of cells to those that were isolated and had neuronal morphology. N T2-N cells tend to form clusters as they differentiate in culture, and cell -cell interactions could possibly effect the differentiation process and resulting cell morphology and might affect neuronal properties. In addition, cell cultures were at best only 99% pure neurons. The contaminating non-neuronal cells were morphologically distinct and could be eliminated by visual selection for electrophysiological experiments.
Solutions and drug application. C ells were removed from the 5% C O 2 incubator, and the feeding medium was replaced with recording medium (in mM: 142 NaC l, 1 C aC l 2 , 6 MgC l 2 , 8.09 KC l, 10 glucose, and 10 H EPES, 315-325 mOsm, pH 7.4). Patch-clamp electrodes of 5-10 M⍀ were filled with pipette solution (in mM: 153.33 KC l, 1 MgC l 2 , 10 H EPES, 5 EGTA, and 2 ATP, 300 -310 mOsm, pH 7.3). This combination of solutions results in nearly equivalent intracellular and extracellular chloride ion concentrations, hence an E C lϪ of ϳ0 mV, and produced an inward current when cells were voltage clamped at negative potentials.
Compounds were applied to cells using a modified U-tube "multipuffer" application system . The U-tube system enabled us to position a micropipette with a 40 -50 m tip next to the cell for the duration of the recording and apply multiple concentrations of individual drugs to each cell. Stock solutions of GABA, diazepam, lanthanum, pentobarbital, phenobarbital, picrotoxin, -one sulfate sodium salt (pregnenolone sulfate), zinc, and zolpidem were made by dissolving each in sterile water. Stock solutions of (3␣)-hydroxy-(5␣)-pregnan-11,20-dione (alphaxalone), bicuculline, methyl-6,7-dimethoxy-4-ethyl-␤-carboline-3-carboxylate (DMC M), f urosemide, and loreclezole were dissolved in dimethylsulfoxide (DMSO) and diluted with sterile water (final DMSO concentration was Ͻ0.1% v/ v). Individual drugs were diluted in recording medium to their final concentration. Alphaxalone and pregnenolone sulfate were purchased from Research Biochemicals (Natick, MA). Loreclezole was obtained from Janssen Biochimica (Berse, Belgium). Bicuculline was purchased from Calbiochem (La Jolla, CA). All other compounds were from Sigma (St. Louis, MO).
Electrophysiolog y. Whole-cell voltage-clamp and single-channel recordings using the patch-clamp technique were obtained as described previously (Hamill et al., 1981) . Patch-clamp electrodes were pulled from Labcraft microhematocrit capillary tubes (Curtin Matheson Scientific, Inc., Houston, TX) or W PI (Sarasota, FL) borosilicate electrode glass (1B150F-3) using a Flaming-Brown P-87 micropipette puller (Sutter Instrument Co., San Rafael, CA). Borosilicate pipettes were fire-polished on a Narashige M F-3 microforge and subsequently coated with polystyrene Q-dope (GC Electronics, Rockford, IL) to reduce electrode tip capacitance.
Whole-cell recordings were performed using an Axopatch 1-B amplifier (Axon Instruments, Foster C ity, CA). Signals were digitized on-line at 200 Hz using a Labmaster TL -1 analog-to-digital converter (ADC), recorded, and subsequently analyzed off-line using Axotape 2.0 software (Axon Instruments). Single-channel recordings were obtained from "outside-out" patches formed using standard techniques (Hamill et al., 1981) with an Axopatch 200A amplifier. Single-channel currents were low-pass-filtered at 2 kHz using an eight pole Bessel filter and subsequently digitized on line at 20 kHz using Axotape 2.0 software. For some later patch recordings, digitization was performed using a Digidata 1200A ADC and Axoscope software (Axon Instruments).
Data anal ysis. The magnitude of the enhancement or inhibition of GABAR current by a drug was measured by dividing the peak amplitude of GABAR currents elicited in the presence of a given concentration of the drug (with GABA) by the peak amplitude of control current elicited by GABA alone and multiplying the fraction by 100 to express it as percent of control. Thus the control response was 100%. Peak GABAR currents at various drug concentrations were fitted to a sigmoidal f unction using a four-parameter logistic equation (sigmoidal concentration -response) with a variable slope. The equation used to fit the concentration -response relationship was:
͑L ogEC50ϪL ogdrug͒‫ء‬Hill slope where I was the GABAR current at a given GABA concentration, and I max was the maximal GABAR current. Maximal current and concentration -response curves were obtained after pooling data from all cells tested for GABA and for all drugs. Concentration -response curves were also obtained from individual cells. The curve-fitting algorithm minimized the sum of the squares of the actual distance of points from the curve. Convergence was reached when two consecutive iterations changed the sum of the squares by Ͻ0.01%. The curve fit was performed on an I BM PC compatible personal computer using Prism 1.0 or 2.0 (Graph Pad, San Diego, CA). Data are presented as mean Ϯ SEM.
To quantif y whole-cell current rectification, peak amplitudes of responses to GABA (at EC 50 concentrations) were measured at holding potentials of Ϫ50 and ϩ50 mV. These responses exhibited no visible desensitization. An amplitude ratio (ϩ50:Ϫ50 mV) was calculated, and rectification was determined with respect to a linear ratio of 1.0 using the predicted E C l of 0 mV. An amplitude ratio Ͼ1.0 indicated outward rectification. To quantif y voltage-dependent differences in desensitization, the amount of desensitization produced by a high concentration of GABA (100 M) was first determined at holding potentials of Ϫ50 and ϩ50 mV. Desensitization was expressed as (1 Ϫ amplitude at end of GABA application)/(peak GABA amplitude). A desensitization ratio (ϩ50:Ϫ50 mV) was then calculated using the method used to characterize rectification. A desensitization ratio Ͻ1.0 was indicative of less desensitization at depolarized membrane potentials.
Single-channel current anal ysis. Analysis of single-channel currents off-line consisted of amplitude and interval detection with Fetchan 6.0 (Axon Instruments) using a 50% threshold detection system, followed by pStat 6.0 (Axon Instruments) for amplitude histograms, and subsequent kinetic investigation using Interval 5 (Dr. Barry S. Palotta, University of North C arolina, Chapel Hill, NC) and software developed in our laboratory (Macdonald et al., 1989) . To reduce errors resulting from multichannel patches, recordings were included in the kinetic analysis only if overlaps of simultaneous openings were very brief and occurred in Ͻ1% of openings. Open and shut duration histograms were constructed as described by Sigworth and Sine (1987) and fit by the maximum likelihood method. The number of exponential f unctions required to fit the binned data was increased until additional components did not significantly improve the fit, as determined by the log-likelihood ratio test (Horn 1987; McManus et al., 1988) . Intervals with durations Ͻ1.5 times the system dead time were displayed in the interval histograms but not included in the fit. Bursts were defined as clusters of openings separated by closures longer than the two shortest closed components, which were thus considered intraburst closures. A critical gap for each patch was calculated from the closed interval distribution to equalize the proportion of misclassified events (Colquhoun and Sakmann, 1985) . Prolonged (30 sec to several minutes) drug applications were used to ensure stationarity of channel activity.
Reverse transcription PCR . Total RNA was isolated from N T2-N neurons using the Ultraspec method by Biotecx (Houston, TX). One microgram of total RNA was treated with DNase in a total volume of 10 l composed of 1 l of 10ϫ DNase I buffer, 1 l of DNase I (1 U/l), and 7 l of DEPC water. This mixture was incubated for 15 min at 25°C. Addition of 1 l of 25 mM EDTA was followed by a 10 min incubation at 70°C to heat inactivate the DNase I. The reaction mixture was then chilled immediately on ice. One microliter of a random primer (0.6 g/l) was then added to the mixture that was then incubated at 25°C for 15 min. Reverse transcription used the product of the above reaction mixed with the following: 1 l of 5ϫ first-strand buffer, 2 l of 0.1 M DTT, 1 l of 10 mM dN TP mix, and 1 l of RNase inhibitor (10 U/l).
The mixture was prewarmed for 2 min at 42°C before addition of 1 l of Superscript II (10 U/l) and then was incubated for 45 min at 42°C. Using the same procedure as described above, with the exception that 1 l of DEPC water was substituted for Superscript II, acted as a negative control. The reverse transcription product was heat-inactivated for 15 min at 70°C before PCR. The PCR reaction was performed for each subunit in 100 l of the following mixture: 1 l of a 20 M primer mixture (3Ј primer and 5Ј primer), 2 l of the reverse transcription product, 10 l of 10ϫ buffer, 16 l of 25 mM MgC l 2 , 1 l of 25 mM dN TP mixture, 0.5 l of Amplitaq (Perkin-Elmer, Norwalk, C T; 5 U/l), and 72.5 l of DEPC -treated water. The templates for the PCR reaction using cDNA for each subunit subtype were used as positive controls. PCR was performed as follows: a 2 min period at 94°C to denature the mixture, 35 cycles at 94°C for 1 min, 55°C for 2 min, 72°C for 1 min, and a 7 min extension period at 72°C. PCR products (5 l for positive controls, 15 l for both test and negative controls) were mixed with dye and run on a 1.5% agarose gel at 120 V for 40 min and then stained with ethidium bromide and photographed. Reaction reagents were purchased from Amplitaq; random primer, Superscript II, RNase inhibitor, and DNase I were purchased from Life Technologies (Gaithersburg, MD); and dN TP mix and DNA molecular weight marker V I were purchased from Boehringer Mannheim (Indianapolis, I N).
RESULTS

NT2-N cell GABAR current
NT2-N cells were voltage-clamped in the whole-cell configuration. Neurons can first be isolated 5 weeks after retinoic acid treatment has begun (Pleasure et al., 1992) . At this time multipolar cells were the predominant cell type found in the cultures, and they were readily identifiable. Immediately on rupturing the membrane for intracellular access, the resting membrane potential was measured for each N T2-N cell by shifting to currentclamp mode with current set at zero. Resting membrane potentials ranged from Ϫ49 to Ϫ33 mV with an average of Ϫ40.9 Ϯ 0.4 mV (n ϭ 118). C ells were then voltage-clamped at Ϫ75 mV, and 300 M GABA was applied for 6 -10 sec to determine whether functional GABARs were expressed on the membrane surface. Whole-cell currents resembled those seen in recordings of native GABARs in mouse cortical neurons (Kume et al., 1996) and recombinant receptors ) with a rapid concentration-dependent rising phase, followed by a decrease in current (despite continued application of GABA), consistent with desensitization. The apparent desensitization occurred at GABA concentrations Ͼ10 M and was typically monoexponential in time course, with faster rates at increased GABA concentrations. Typical current traces from an N T2-N cell are shown in Figure  1 A. Peak amplitudes of N T2-N cell responses (n ϭ 12) to a range of GABA concentrations (300 nM to 300 M) were pooled and fitted to a sigmoidal logistic f unction (EC 50 , 21.8 M; Hill slope, 1.2) (Fig. 1 B) . Individual EC 50 values ranged from 7 to 80 M with an average of 31.3 Ϯ 8.3 M. NT2-N cells had an average maximal current of 472.4 Ϯ 70.5 pA at 300 M GABA (n ϭ 12).
Voltage dependence of GABAR currents
The degree and direction of GABAR current rectification depended on the GABAR isoform (Burgard et al., 1996) . Wholecell current-voltage ( I-V) relations were generated in NT2-N cells by measuring peak currents evoked by 30 M GABA at holding potentials from Ϫ100 to ϩ75 mV at 25 mV increments. In all cells studied (n ϭ 6), there was no evidence of inward or outward current rectification. A plot of the average peak current at each holding potential for the four cells in which the complete I-V relations were generated resulted in a linear I-V plot ( p Ͻ 0.001) (Fig. 2 ). An amplitude ratio of 0.90 Ϯ 0.90 was calculated for six cells by dividing the peak current evoked at ϩ50 mV by the peak current evoked at Ϫ50 mV. This again indicates that there was no rectification in either direction, because the amplitude ratio was not significantly different from unity (see Materials and Methods).
Voltage-dependent desensitization to high concentrations of GABA was also dependent on the GABAR isoform expressed (Burgard et al., 1996) . In the continued presence (15 sec) of 100 M and higher GABA concentrations, there was a prominent exponential decrease in amplitude from peak until the agonist was removed. The rate of apparent desensitization increased with higher GABA concentration. With our application system, rapid desensitization (time constants Ͻ50 msec) could not be recorded, but slower desensitization (time constants Ͼ100 msec) could be characterized. To determine whether this apparent desensitization was voltage-dependent, cells were held at ϩ50 and Ϫ50 mV for sequential 15 sec applications of 100 M GABA. The current amplitude at the end of the application was divided by the peak (initial) current for each holding potential. The desensitization ratio for the four cells tested was 1.01 Ϯ 0.12 (see Materials and Methods), indicating no voltage dependence of desensitization during applications of 100 M GABA at these holding potentials.
Single-channel currents
Single-channel currents were recorded in the outside-out configuration from a total of 116 GABA applications onto 19 excised patches in six separate experiments. However, most of these patches were not used for kinetic analysis because of the large number of overlapping or multiple openings, suggesting a high density of GABAR channels in the NT2-N cell membrane. Five patches were obtained in four of these experiments in which single openings predominated during applications of 1, 3, and 10 M GABA. Data from these patches were used for most of the kinetic and amplitude analysis (see Materials and Methods).
GABAR single-channel currents opened singly and in bursts of multiple openings (Fig. 3A) . At least two conductance levels were observed at most holding potentials: a main conductance level of 23 pS in which the majority of openings were classified and a subconductance level of ϳ19 pS (Fig. 3B) . Rare openings to a conductance level of ϳ27 pS were observed more commonly at negative than positive holding potentials. A current-voltage relationship was obtained by holding the membrane potential at voltages from Ϫ80 to ϩ80 mV in 20 mV steps during sequential applications of 3 M GABA. Openings were detected using a 50% threshold based on the amplitude of the main (23 pS) conductance level and thus included both the subconductance (19 pS) and larger conductance level (27 pS) openings. Event amplitude histograms were best fit using three Gaussian f unctions; the statistical means of these f unctions for a single patch are displayed in the current-voltage relationship shown in Figure 3B . Linear regressions of mean amplitudes at each holding potential showed reversal of single-channel currents at ϳ0 mV for all three conductance levels, consistent with the reversal potential for chloride with these solutions. None of the three conductance levels demonstrated either inward or outward rectification at the holding potentials examined. An example of the amplitude histogram for openings in a different patch held at ϩ50 mV (Fig. 3C ) and Ϫ50 mV (Fig. 3D ) demonstrates symmetrical conductance levels (i.e., no inward or outward current rectification), although the relative proportion of main to subconductance level openings was somewhat larger at more negative potentials. The relative proportion of 27 pS openings was small (5-10%) at both positive and negative holding potentials in most patches.
The frequency of single-channel openings increased with increasing GABA concentration, from 10.4 openings/sec during application of 1 M GABA to 28.8 openings/sec with 10 M GABA (Table 1) . Mean open time also increased slightly from 1.4 to 1.6 msec, and the percentage of time open increased from 1.8 to 5.2%, consistent with both longer burst openings and increased opening frequency at increased GABA concentration. The mean closed time diminished as GABA concentration increased. Openduration histograms from selected patches with minimal overlapping or multiple openings were fitted best with three exponential functions, suggesting three open time constants with durations of 0.2, 1.5, and 4.5 msec (Fig. 4 A, Table 2 ). These time constants did not change significantly with GABA concentration, but the percentage of openings classified in each exponential distribution varied with GABA concentration. With 1 M GABA, most of the openings were classified in the shortest (O1) distribution (57%) with smaller proportions of openings in the two longer opening classes (23% O2 openings and 12% O3 openings). As GABA concentration increased, the percentage of O1 openings decreased, and the percentage of longer openings increased (Fig.  4 A) , as predicted by models in which the binding of more than one GABA molecule drives the channel into longer open states (Macdonald et al., 1989) . However, with 10 M GABA, a concentration at which almost all openings would be expected to be in the O2 and O3 classes, there were still a large number of O1 openings. This may have resulted from "trapping" of liganded channels in a desensitized distal closed state, from which recovery was slow enough that brief applications of GABA (lasting 30 -60 sec) were biased toward sampling channels in the O1 and O2 states.
Closed-duration histograms were fitted best with five exponential functions (Fig. 4 B) . As GABA concentration increased, the durations of the three longer closed states (C3, C4, and C5) decreased, whereas the durations of the two short states (C1 and C2) did not change (Fig. 4 B) . This was consistent with previous observations in our laboratory (Twyman et al., 1990; and the interpretation that the C1 and C2 states represent intraburst closures. Histograms of burst durations pooled for each GABA concentration (based on a critical gap determined for each patch) were fitted best with three exponential distributions whose time constants did not change significantly between 1 and 3 M GABA (1.27, 3.07, and 24.4 msec for 1 M GABA; 1.96, 2.32, and 24.7 msec for 3 M GABA) (data not Responses were obtained at V h levels of both ϩ50 and Ϫ50 mV. The response recorded at Ϫ50 mV has been inverted and superimposed on the ϩ50 mV trace for comparison. The degree of desensitization was calculated by dividing the current remaining at the end of GABA application (arrow) by the peak response (see Materials and Methods).
shown), but the proportions shifted from shorter to longer burst durations (64.5, 22.5, and 12.8% for shortest to longest durations for 1 M GABA vs 31.0, 28.2, and 40.6% for 3 M GABA). There was an increase in mean burst duration from 3.9 at 1 M GABA to 10.8 msec at 3 M GABA, with a concomitant increase in mean openings per burst from 3.6 to 4.9 (Table 1) . At 10 M GABA, however, mean burst duration and the number of openings per burst decreased to 6.6 and 3.1 msec, respectively, again probably because of entry into desensitized states from which recovery may be slow.
Pharmacology of GABAR currents
Individual N T2-N neurons were tested for their responsiveness to a variety of GABAR modulators. In each of the cells tested with all of the following drugs (n ϭ 3), the positive allosteric modulators diazepam (300 nM), loreclezole (3 M), and pentobarbital (100 M) enhanced currents evoked by 10 M GABA (Fig. 5A) , whereas the negative allosteric modulators zinc (100 M), bicuculline (100 M), and picrotoxin (30 M) inhibited currents evoked by 30 M GABA (Fig. 5B) . GABAR currents in NT2-N cells were further studied to characterize the pharmacology of NT2-N GABARs in greater detail with a variety of compounds that modulate GABAR function (Table 3) .
Barbiturates
Both pentobarbital (Fig. 6 A) and phenobarbital (Fig. 6 B) enhanced whole-cell GABAR currents evoked by 10 M GABA. Pentobarbital maximally enhanced GABA-evoked currents by 434 Ϯ 60% at 200 M (n ϭ 6) with an apparent EC 50 of 41.3 M and Hill slope of 1.47 (Fig. 6C) . Phenobarbital maximally enhanced GABAR current to 331 Ϯ 37% of control at 3 mM but was ϳ10-fold less potent with an apparent EC 50 of 412 M and a Hill slope of 2.21 (n ϭ 5) (Fig. 6C) .
Benzodiazepines
Diazepam (300 nM) enhanced whole-cell GABAR currents evoked by 10 M GABA (Fig. 7A) . Diazepam maximally enhanced GABAR current to 340 Ϯ 42% (n ϭ 5) of control at 100 nM diazepam with an apparent EC 50 of 74.2 nM and a Hill slope of 1.08 (Fig. 7D) . Concentration-response curves were obtained in five cells by coapplication of diazepam with 10 M GABA.
Zolpidem
The imidazopyridine zolpidem is another GABAR benzodiazepine site agonist sensitive to the ␣ subunit subtype. Zolpidem (10 M) enhanced GABAR currents evoked by 10 M GABA in all but one of the NT2-N cells studied (eight of nine) (Fig. 7B) . Zolpidem enhanced GABAR currents with moderate affinity when coapplied with 10 M GABA (EC 50 , 527 nM; Hill slope, 0.99) (Fig. 7D) . Shown is a summary of kinetic properties of single channel GABAR currents evoked by 1, 3, and 10 M GABA. Major kinetic properties of single channel openings are represented as the means and SEM for the number of patches indicated. The burst properties were determined from the pooled data from all analyzed patches.
DMCM
DMCM is a ␤-carboline that acts as an inverse agonist at the benzodiazepine site. DMC M (3 M) reduced whole-cell GABAR currents evoked by 30 M GABA (Fig. 7C) . DMC M produced a maximal reduction of 44.6 Ϯ 5.2% of GABAR current (n ϭ 9)
with an IC 50 of 44.8 nM and Hill slope of Ϫ1.12 (Fig. 7D) . Eight of the nine cells tested showed inhibition of the current across the range of DMCM concentrations tested. However, in one cell GABAR currents were enhanced at concentrations up to 30 nM and inhibited at higher concentrations. A, Open-duration histograms for a single patch exposed to 1, 3, and 10 M GABA. Open times were best fit by three exponential distributions with time constants and proportions as reported in Table  2 . B, Closed-duration histograms for a single patch exposed to 1, 3, and 10 M GABA. C losed times were best fit by five exponential distributions with time constants and proportions as reported in Table 2 . 
Loreclezole
The novel anticonvulsant drug loreclezole interacts with a site on the ␤2 and ␤3 subtypes to enhance GABAR currents . L oreclezole enhanced GABAR currents evoked by 10 M GABA in every cell tested (n ϭ 5) (Fig.  8 A) . Peak enhancement occurred at 10 M loreclezole (240 Ϯ 46%), but the degree of enhancement decreased at 30 M loreclezole (148 Ϯ 23%) for all five cells tested (Fig. 8) , as previously reported for recombinant ␣5␤3␥2 GABARs (Donnelly and . To determine the EC 50 for loreclezole, only the responses between 100 nM and 10 M were used to generate the concentration -response relationship. Under these conditions, the loreclezole EC 50 was 1.22 M with a Hill slope of 3.26 (n ϭ 5) (Fig. 8 B) .
Neurosteroids
Neurosteroids have been shown to differentially modulate GABAR currents. Alphaxalone (5␣-pregnan-3␣-ol-11,20-dione) and pregnenolone sulfate (5-pregnan-3␤-ol-20-one sulfate sodium salt) are neurosteroids that enhance and inhibit GABAR currents, respectively. Alphaxalone (10 M) enhanced currents elicited by GABA (10 M) by 431 Ϯ 31% (n ϭ 4). Increasing concentrations of alphaxalone (30 nM to 30 M) resulted in greater enhancement of the peak current (Fig. 9A) . A concentration -response curve of the enhancement of peak GABAR current relative to control was fit with a fourparameter logistic equation yielding an apparent EC 50 of 414 nM and a Hill slope of 0.94 (Fig. 9B ). Pregnenolone sulfate (10 pM to 10 M) decreased GABAR currents (Fig. 9C ) in a concentration-dependent manner starting at 1 nM with a maximal inhibition of 67.5 Ϯ 1.9% at 10 M (Fig. 9D ). An accurate IC 50 for pregnenolone sulfate could not be calculated, because 10 M was near the limit of solubility. However, fitting the data with a logistic equation where I max was set at 0% yielded an equation with an apparent IC 50 of 4.9 M and a Hill slope of Ϫ0.50.
Bicuculline
Bicuculline is a competitive GABAR antagonist and has no effect on GABA B receptors, GABA C receptors, or the phylogenetically and structurally similar glycine receptor (Macdonald and Olsen, 1994) . Bicuculline inhibits current at any functional GABAR isoform, irrespective of subunit composition. Currents evoked by showing maximal enhancement) . B, Representative current traces showing current evoked by 10 M GABA and enhancement by 300 M and 3 mM phenobarbital (PhB). Horizontal bars, Drug applications made at 2 min intervals. C, Concentration -response curves for enhancement of 10 M GABAR peak currents by PB (n ϭ 6) and PhB (n ϭ 5). Ordinate, Percent of peak response to 10 M GABA is displayed. Data are mean Ϯ SEM. 30 M GABA in N T2-N cells were inhibited by bicuculline (10 nM to 30 M) (EC 50 , 1.1 M; Hill slope, Ϫ0.72) (Fig. 10 A,C) . Currents elicited by 30 M GABA were completely blocked by coapplication of 100 M bicuculline.
Furosemide
Furosemide, an anthranilic acid derivative, inhibits recombinant GABAR currents with IC 50 s in the micromolar range, but only when either an ␣4 or ␣6 subunit is present (Wafford et al., 1996) . Furosemide (10 M to 3 mM) inhibited N T2-N GABAR currents evoked by 30 M GABA only at concentrations Ͼ100 M (Fig.  10 B) . The greatest inhibition observed was 78.2 Ϯ 1.2% at 3 mM furosemide; concentrations Ͼ3 mM could not be achieved because of limits of solubility; hence, true maximal inhibition could not be assessed. However, fitting the data with a logistic equation where I max was set at 0% produced an apparent IC 50 of 1.4 mM and a Hill slope of Ϫ1.3 (Fig. 10C) .
P icrotoxin
Picrotoxin, a noncompetitive GABAR antagonist, also inhibited NT2-N GABAR currents. Picrotoxin (30 M) blocked 71.5% of the peak current evoked by 30 M GABA (n ϭ 8) (data not shown). A complete concentration -response curve was not generated because of the long-lasting effects of moderate concentrations of picrotoxin (Table 3) .
Pol yvalent cations
The divalent cation zinc (Z n 2ϩ ) is a noncompetitive antagonist of GABAR currents. Z n 2ϩ (300 nM) reduced whole-cell GABAR currents evoked by 30 M GABA (Fig. 11 A) . Inhibitory concentration -response curves were generated by increasing the concentration of Z n 2ϩ (100 nM to 1 mM) coapplied with a concentration of GABA near the EC 50 for N T2-N cells (30 M) (Fig. 11C) . The IC 50 for Z n 2ϩ was 14.7 M with a Hill slope of Ϫ0.43 (n ϭ 5). GABAR currents were almost completely blocked by 1 mM Zn 2ϩ (94.8 Ϯ 1.7%).
The trivalent cation lanthanum (La 3ϩ ), when coapplied with a GABA concentration near the EC 50 , inhibits ␣6-containing GABARs and enhances ␣1-containing GABARs (Saxena et al., 1997) . La 3ϩ (100 nM to 1 mM) was coapplied with either 10 M (data not shown) or 30 M GABA to NT2-N cells (Fig. 11 B) . La 3ϩ had little effect on peak GABAR currents elicited by either GABA concentration. There were no statistically significant changes at lower La 3ϩ concentrations. A small (22.5 Ϯ 4.8%) but significant inhibition of GABAR currents evoked by 30 M GABA was seen at 1 mM La 3ϩ (n ϭ 11) (Fig. 11C) .
Distribution of maximal effects on individual neurons
The pharmacological data for the allosteric modulators that were tested are summarized in Table 3 . The maximal effect was statistically compared with control GABA currents for each cell using paired t tests. Statistical significance was reached for each compound (*p Ͻ 0.05; **p Ͻ 0.01; and ***p Ͻ 0.001). Normalized maximal effects of all compounds tested on individual cells were evenly distributed around the mean and not separated into distinct groups.
PCR analysis of GABAR subunit mRNAs
Total RNA was isolated from cultures of NT2-N cells at the same 5 week time point that electrophysiological studies were performed. Reverse transcription PCR (RT-PCR) was used to determine the presence or absence of GABAR subunits using primers specific for human ␣1-6, ␤1-3, ␥1-3, , and ⑀ subunit subtypes (Table 4) . In repeated experiments, major bands were found for ␣2, ␣3, ␣5, ␤3, ␥3, and subtypes (Fig. 12) , whereas bands for ␣1, ␤2, ␥1, and ␥2 subtypes were not found. Faint bands for the remaining subtypes (␣4, ␣6, and ␤1) were inconsistently found. Primers designed to amplify the ⑀ subunit did not amplify products of the predicted molecular size. Multiple primers were designed for the ␥3 subtype. The molecular masses of the PCR products were slightly larger than the cDNA-positive control when the primers amplified the entire N-terminal domain to the first intracellular loop [amino acids (aa) 18 -267]. However, when the primers were designed to amplif y only part of the N-terminal domain (aa 110) to midway through the large intracellular loop between M3 and M4 (aa 413), the PCR products were the same molecular mass as the cDNA control (data not shown). These same primers were unable to amplif y either the ␥1 or ␥2 subtype, suggesting that the ␥3 subtype expressed in N T2-N cells may represent a longer splice variant than previously described. DISCUSSION NT2-N cells express primarily ␣2, ␣3, ␣5, ␤3, ␥3, and GABARs subtype mRNAs High mRNA levels for the ␣2, ␣3, ␣5, ␤3, ␥3, and subtypes were found using RT-PCR performed on total RNA isolated from NT2-N cells. Minimal mRNA levels for ␣4, ␤1, and ␥1 subtypes were found in some, but not all, of the experiments, and no transcripts encoding human ␣1, ␣6, ␤2, or ␥2 subtypes were detected. The pharmacological data suggested that a limited number of subunit subtypes were endogenously expressed in functional GABARs in N T2-N cells, which was confirmed by the use of RT-PCR. These subtype mRNAs were consistent with most of the pharmacological properties of GABAR currents recorded from N T2-N cells. Because RNA was isolated from an entire 10 cm dish of cells with no preference for cell type, we cannot rule out the possibility that there were subpopulations of NT2-N cells that expressed different isoforms based on either the stage of differentiation or differences in cell fate. It is unlikely that retinoic acid treatment alone would cause multiple fates of clonal NT2 stem cells. However, it is possible that multiple cell fates could occur during the differentiation process caused by secondary factors such as cell-cell or cell-substrate interactions that may alter the major GABAR isoforms being expressed. The possible existence of subpopulations of cells may also explain the low levels of ␣4, ␣6, and ␤1 mRNA and the inconsistency of their presence across RNA preparations. Although it is unlikely that NT2-N cells differentiate into a specific neuronal population found in the developing vertebrate brain, it is interesting to note that the subunits found expressed at high levels in NT2-N cells at this time point are located on chromosomes 15 (␣5, ␤3, and ␥3) and X (␣3). With the exception of the ␣2 subtype mRNA, those barely detected were located on chromosome 4 (␣2, ␣4, ␤1, and ␥1), and those not expressed at all were located on chromosome 5 (␣1, ␣6, ␤2, and ␥2) (Rabow et al., 1995) . The subunits expressed in NT2-N cells have been shown to be primarily expressed early in the development of the rat brain , whereas those located on chromosome 5 are the predominate subunits found in adult rat brains . NT2-N cells resemble immature CNS neurons, as determined by markers such as fetal , the incomplete phosphorylation state of high molecular weight neurofilament protein, and no MAP2b expression (Pleasure et al., 1992) . Further studies are under way to determine whether all N T2-N cells contain all subtype mRNAs or whether there are multiple populations of cells with identifiable morphologies that contain different combinations of messages and whether the N T2 cell line undergoes a developmental switch in subunit expression similar to that found in rat brain.
NT2-N cells express GABARs likely composed
primarily of ␣2, ␣3, ␣5, ␤3, and ␥3 subtypes Differentiated NT2-N neurons expressed GABARs with a distinct set of pharmacological and biophysical properties and expressed a limited number of GABAR subtype mRNAs. High ) . B, Representative current traces of furosemide inhibition of 30 M GABA-evoked currents at control levels (GABA alone), ϩ100, 300 M FUR and maximal concentration (ϩ3 mM FUR). C, Concentration-response curves for inhibition of peak current amplitudes by BIC (n ϭ 5) and FUR (n ϭ 5). Either BIC or FUR was coapplied with 30 M GABA. Data are mean Ϯ SEM. levels of ␣2, ␣3, ␣5, ␤3, ␥3, and subunit subtype mRNAs were consistently amplified using RT-PCR performed on total RNA isolated from N T2-N cells. These data suggest that N T2-N cells express a limited number of GABAR isoforms with relatively uniform biophysical and pharmacological properties. N T2-N cells constitute the only known human-derived clonal cell line that express f unctional GABARs; therefore, they provide a unique preparation for investigation of human GABAR expression, assembly, structure, and regulation. Studies using nonhuman recombinant GABAR subunits have shown that the affinity and efficacy for many GABAR modulators, as well as certain biophysical properties, depend on the expressed isoform. Although no definitive conclusions about the subunit subtype composition of GABARs can be made by determination of pharmacology and kinetic properties, several pharmacological and biophysical properties of N T2-N GABARs limit the possible expressed subtypes. Possible subtypes can be further limited by comparison of the pharmacological, biophysical, and RT-PCR data.
All N T2-N cells responded to GABA with a mean GABA EC 50 of 21.8 M, and individual EC 50 values and maximal peak amplitudes were evenly distributed around the mean. Recombinant GABARs expressing rat or bovine ␣, ␤, and ␥ subunits had EC 50 values ranging from 1-50 M, whereas GABARs expressing ␣␤⑀, ␣␤␦, or ␣␤ subunits alone had lower GABA EC 50 values, ranging from 0.5 to 5 M Saxena and Macdonald, 1994 ) (T. R. Neelands and R. L. Macdonald, unpublished results) . Thus, N T2-N cell GABARs had a GABA EC 50 that was consistent with an isoform containing ␣, ␤, and ␥ subunits.
NT2-N GABARs likely contain a ␥3 subtype
Enhancement of GABAR currents by benzodiazepine site ligands requires the presence of a ␥ subunit in the receptor (Knoflach et al., 1991; Luddens et al., 1994; Hadingham et al., 1995; Benke et al., 1996) . Because NT2-N cells expressed high levels of mRNA for ␥3, but not ␥1 or ␥2 subtypes, and GABAR currents were enhanced by diazepam, zolpidem, and reduced by DMCM, it is likely that NT2-N GABARs contain a ␥3 subtype.
NT2-N GABARs likely contain ␣2 and/or ␣3 subt ypes
Recombinant GABARs with high affinity for benzodiazepines contain the ␣1 subtype, and low-affinity receptors contain either ␣4 or ␣6 subtypes when coexpressed with ␤ and ␥ subtypes. Receptors with moderate affinity for diazepam can be further divided based on moderate affinity (␣2-or ␣3-containing receptors) or insensitivity (␣5-containing receptors) to zolpidem. In addition, DMCM, an inverse agonist at the benzodiazepine site, inhibited GABARs containing ␣1, ␣2, ␣3, and ␣5 subtypes but enhanced GABARs containing ␣4 and ␣6 subtypes. Furosemide is a high-affinity antagonist of recombinant rat GABARs that contain either ␣4 or 6 subtypes (Wafford et al., 1996) when coexpressed with ␥ and ␤2 or ␤3, but not ␤1, subtypes (Korpi et al., 1995) . The cation lanthanum enhances ␣1-containing receptors but inhibits ␣6-containing GABARs (Saxena et al., 1997) when coexpressed with a ␤ and ␥ or ␦ subunit. The ␣ subtype alters the magnitude and affinity of zinc block. GABARs containing ␣2 and ␣3 subtypes were blocked by zinc to a greater extent but with lower affinity than GABARs containing the ␣1 subtype (White and Gurley, 1995) .
GABAR currents evoked from N T2-N cells were potenti- Figure 11 . Effects of poly valent cations on GABAR currents. A, Representative current traces of Z n 2ϩ inhibition of 30 M GABA-evoked currents at control levels (GABA alone), IC 50 concentration (ϩ10 M Zn 2ϩ ), and maximal concentration (ϩ1 M Zn 2ϩ ). B, Representative current traces of La 3ϩ inhibition of 30 M GABA-evoked currents at control levels (GABA alone), ϩ100 M La 3ϩ and maximal concentration (ϩ1 mM La 3ϩ ). Horizontal bars, Drug applications made at 2 min intervals. C, Concentration-response curves for the effects of the poly valent cations Zn 2ϩ (n ϭ 5) and La 3ϩ (n ϭ 11) on peak current amplitudes. Either Zn 2ϩ or La 3ϩ was coapplied with 30 M GABA. Data are mean Ϯ SEM. ated by both diazepam and zolpidem with only moderate affinity, suggesting the presence of an ␣2 and /or ␣3 subtype. DMC M inhibited GABAR currents with a moderate affinity; f urosemide blocked GABAR current with low affinity; lanthanum had no significant effect on the currents; and zinc had an apparent affinity of 14.7 M, almost completely blocking (95%) the current at 1 mM, suggesting that the major isoform expressed in N T2-N GABARs did not contain ␣1, ␣4, and ␣6 subtypes. The zinc affinity was similar to that reported for dentate granule cell GABARs (28 M; Kapur and Macdonald, 1996) and for ␣5␤3␥2L receptors (22 M; Burgard et al., 1996) but was higher than described for ␣␤ combinations (ϳ560 nM) (Draguhn et al., 1990) . A combination of the subunits identified by RT-PCR (␣2, ␣3, and /or ␣5, ␤3, and ␥3) would be consistent with the effect of zinc as well as the potentiation by diazepam.
These data suggest that N T2-N cells might express ␣2 and /or ␣3 subtypes and likely do not express ␣1, ␣4, or ␣6 subtypes. The RT-PCR study demonstrated the presence of ␣5 in addition to ␣2 and ␣3 subtype mRNAs. Although ␣5 is expressed, the enhancement of N T2-N currents by zolpidem argues against incorporation of ␣5 into the major isoform expressed by N T2-N cells. Taken together, these data are consistent with the presence of ␣2 and /or ␣3 subtypes coassembled with ␤ and ␥ subtypes.
NT2-N GABARs likely contain the ␤3 subtype
Loreclezole enhancement of recombinant rat GABARs acts at a specific modulatory site on the ␤2 and ␤3, but not ␤1, subtypes . In addition, when ␤1 and ␤3 were coexpressed, loreclezole sensitivity was similar to that of the lowaffinity ␤1-containing isoforms (Donnelly and Macdonald, 1996) . High levels of message for ␤3 in NT2-N cells with little or no message for ␤1 or ␤2 would predict high-affinity enhancement of GABA-evoked currents by loreclezole. GABA-evoked currents in NT2-N cells were enhanced by loreclezole with a calculated Primers used to direct PCR amplification of human GABAR mRNAs expressed in NT2-N cells and the cDNA positive controls. The sequences of the primer pairs used to amplif y each subunit, the fragment size (in base pairs), and the region amplified were included.
affinity consistent with those previously reported for recombinant rat GABARs. These data, along with the RT-PCR findings, support the incorporation of only the ␤3 subtype into the major NT2-N GABAR isoform.
NT2-N GABAR biophysical properties were consistent with an ␣, ␤, and ␥ subunit subtype containing isoform
Single GABAR channels pulled from N T2-N cells opened in bursts to three different conductance levels: 19, 23, and 27 pS. These conductance levels were similar to those observed in native GABAR isolated in membrane patches from cultured mouse spinal neurons (Bormann et al., 1987) and cultured chick neuron patches (Weiss et al., 1988) . Single-channel studies of recombinant rat GABARs have shown similar conductance levels of 29 and 21 pS for GABAR isoforms composed of ␣1, ␤1, and ␥2S subunits but 15 and 10 pS for GABARs composed of ␣1 and ␤1 Moss et al., 1990) . Kinetic analysis of the main conductance level openings suggested the presence of three open states and five closed states, similar to those determined in our laboratory for native GABAR channels in outside-out patches obtained from mouse spinal cord neurons in primary cell culture (Macdonald et al., 1989) . A limited burst analysis showed concentration-dependent burst distributions similar to previously reported native and recombinant receptors. In most respects, however, the kinetic behavior of NT2-N single-channel GABAR openings was consistent with that reported in earlier studies.
Although studies of recombinant rat or bovine GABAR singlechannel currents have not demonstrated a particular conductance level or kinetic "fingerprint" for specific isoforms, isoforms containing only an ␣ and ␤ subunit generally resulted in smaller single-channel conductance levels compared with ␥-containing receptors and only two rather than three open states. To date no other detailed single-channel analysis has been done on human recombinant receptors or native isoforms from human tissue. Therefore, because this is the first single-channel description of human GABARs, only limited comparisons can be made between this study and previous work. However, the single-channel currents of NT2-N cells are remarkably similar in the pattern and level of their openings to other native GABA receptors and are consistent with the RT-PCR and pharmacological results, suggesting that the native NT2-N GABAR is composed of an ␣, ␤, and ␥ subunit. . In some lanes, bands of lower molecular mass than that predicted for the product of interest, which are nonspecific PCR amplification products, were stained (Bloch, 1991) .
